Technology News and Research

RSS

HSR waiting period for vRad and NightHawk's proposed merger terminated

Virtual Radiologic (vRad) and NightHawk Radiology, announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for vRad's previously announced proposed merger with NightHawk, has terminated.

9 Nov 2010

Priaxon and Technical University Munich partner to develop anti-infective agents against infectious diseases

Priaxon AG, Munich, and the University Hospital Rechts der Isar (Technical University Munich) announce their cooperation for the development of new, highly selective anti-infective agents against a novel protein target class of widely spread infectious diseases. Their joint project is supported in the framework of the top cluster support project of the German Federal Ministry of Education and Research, coordinated by BioM GmbH.

9 Nov 2010

Innovative method for in-cell gene manipulation

A cross-disciplinary Small Medicine and Advanced Research Translation (SMART) team led by Prof. Dar-Bin Shieh of Institute of Oral Medicine in Medical College at National Cheng Kung University (NCKU), Tainan, Taiwan, has announced a breakthrough in the precision in-cell gene scission at pre-designed sequence sites using Artificial Targeting Light Activated Nano Scissors (ATLANS) and a custom build photonic device.

9 Nov 2010

Angiotech reports $59.0 million total revenue for third quarter 2010

Angiotech Pharmaceuticals, Inc. today announced that it had released its financial results for the third quarter ended September 30, 2010.

9 Nov 2010

Food insecurity may cause problem for diabetic patients living on fixed incomes

The economic recession impacts many aspects of our lives including an increase incidence of food insecurity. This can have serious consequences for those suffering from chronic illnesses like diabetes.

9 Nov 2010

Endeca, eHealth Ontario partner to implement chronic disease management system

Endeca Technologies, Inc., a search and business intelligence (BI) company, today announced that eHealth Ontario, an agency of the Government of Ontario, has selected Endeca and commenced work on the chronic disease management system (CDMS) and portal project previously announced in August 2010. Endeca, working with its partners, will assist with the design, build, and implementation of the system that will be used initially to better manage diabetes care throughout the province.

9 Nov 2010

Mobile technology improves diagnosis and treatment for mothers, newborns and children

Simple mobile technology, like basic cell phones, can be used to save the lives of mothers in childbirth, and improve the care of newborns and children, reaching underserved populations in remote areas.

9 Nov 2010

Multidetector CT helps pinpoint causes of ischemic stroke

Multidetector computed tomography (CT) helps pinpoint the causes of ischemic strokes, the most common type of stroke, potentially speeding the delivery of life-saving treatments, according to a study published online and in the January issue of Radiology.

9 Nov 2010

Intercell aggregate revenues decrease 28.4% to EUR 21.1m in 9 months ended September 30, 2010

Today, Intercell AG announced its financial results for the third quarter of 2010 and presented an update on the Company's key R&D programs as well as changes to the Management Board.

9 Nov 2010

Scientists develop nanobioconjugate drug to target brain tumor

Nine years ago, scientists at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute detected a subtle shift occurring in the molecular makeup of the most aggressive type of brain tumors, glioblastoma multiforme. With further study, they found that a specific protein called laminin-411 plays a major role in a tumor's ability to build new blood vessels to support its growth and spread. But technology did not exist then to block this protein.

9 Nov 2010

Study confirms defect in sweat gland function as disease biomarker for XLHED

Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced key findings of a study exploring novel approaches to the assessment of sweat function in males with XLHED. Affected individuals lack a normal sweat response, placing them at life-long risk for clinically-significant hyperthermia.

9 Nov 2010

Medisafe 1 website highlights ways to prevent incorrect medications

Medisafe 1 Technologies Corp. a developer of patented technologies that physically prevent the unauthorized administration of prescription medications, announced today that the company has uploaded a product presentation on the company's new website.

9 Nov 2010

Food security conference in The Hague concludes with suggestions for U.N. climate negotiations to incorporate agriculture

Participants in a five-day food security meeting at The Hague "urged U.N. climate negotiators Friday to consider agriculture when drawing up strategies to fight climate change," the Canadian Press reports.

9 Nov 2010

Cook Medical's controlled-release esophageal stent receives FDA clearance

Cook Medical's controlled-release esophageal stent fully covered in silicone has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), making available yet another advanced solution from Cook Medical, the only full-line supplier of endoscopic devices.

9 Nov 2010

Firms pursue new digital technologies to meet stimulus- and health law-fueled provider demand

The Washington Post: "A growing number of companies are joining five-year-old AFrame Digital in offering products that link heath care with mobile and other remote technologies in an effort to increase the quality and reduce the cost of medical treatment. Health-care legislation made heaps of money available to digitize medical records and bolster the industry's information technology, including programs to foster innovation" (Overly, 11/8).

9 Nov 2010

Fabrus, Ambrx commence joint research program for antibody drug conjugates

FABRUS, LLC announces that the Company and San Diego-based Ambrx Inc. have commenced a joint research program to discover antibodies with properties that are optimized for use as antibody drug conjugates.

9 Nov 2010

CorMatrix receives $2.3 million grants under QTDP program to advance ECM technology

CorMatrix Cardiovascular, Inc., a medical device company dedicated to developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, today announced that the Company has been awarded $2.3 million in grants under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program to advance the development of their unique ECM technology.

9 Nov 2010

Doctors abandon traditional practice for concierge medicine, hospital employment

The Palm Beach Post, on the growth of concierge medicine: "As health reform prepares to send another 32 million people into the already stressed health system, some say that concierge medicine is the future — where the wealthy see the best primary care doctors in a luxury setting, and everyone else makes do with clinics staffed by 'physician extenders' such as nurse practitioners.

8 Nov 2010

New COLD-PCR technology to detect EGFR gene mutation

Transgenomic, Inc. today announced completion of a development study of several new assays to detect genetic mutations using the Company's proprietary Co-amplification at Lower Denaturing Temperature PCR (COLD-PCR) technology in the Epidermal Growth Factor Receptor (EGFR) gene.

8 Nov 2010

Health reform updates: Biotech grants, privacy issues and birth control coverage

Firms vying to tap the fund a $1 billion fund meant to catalyze research on new biologic treatments for cancer and other diseases may be disappointed in the outcome, The Washington Post reports. "[W]ith so many companies applying for a share of the money, many firms got much smaller allotments than requested and said the financial boost won't go as far as they had initially hoped.

8 Nov 2010

Technology News and Research

HSR waiting period for vRad and NightHawk's proposed merger terminated

Priaxon and Technical University Munich partner to develop anti-infective agents against infectious diseases

Innovative method for in-cell gene manipulation

Angiotech reports $59.0 million total revenue for third quarter 2010

Food insecurity may cause problem for diabetic patients living on fixed incomes

Endeca, eHealth Ontario partner to implement chronic disease management system

Mobile technology improves diagnosis and treatment for mothers, newborns and children

Multidetector CT helps pinpoint causes of ischemic stroke

Intercell aggregate revenues decrease 28.4% to EUR 21.1m in 9 months ended September 30, 2010

Scientists develop nanobioconjugate drug to target brain tumor

Study confirms defect in sweat gland function as disease biomarker for XLHED

Medisafe 1 website highlights ways to prevent incorrect medications

Food security conference in The Hague concludes with suggestions for U.N. climate negotiations to incorporate agriculture

Cook Medical's controlled-release esophageal stent receives FDA clearance

Firms pursue new digital technologies to meet stimulus- and health law-fueled provider demand

Fabrus, Ambrx commence joint research program for antibody drug conjugates

CorMatrix receives $2.3 million grants under QTDP program to advance ECM technology

Doctors abandon traditional practice for concierge medicine, hospital employment

New COLD-PCR technology to detect EGFR gene mutation

Health reform updates: Biotech grants, privacy issues and birth control coverage

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News